Authors



Katherine Seay, inVentiv Health

Latest:

Future look: The Impact of Biosimilars on Oncology

Marketing strategies will adjust with the advent of biosimilars



Craig Robertson, Accenture

Latest:

A managed services approach to sales and marketing

Applying the managed services model to commercial operations can result in dramatic savings as pharma companies globalize



Kiaema R. Reid, Porzio Pharmaceuitcal Services LLC

Latest:

The end or just the beginning? Exploring federal preemption of state marketing and distribution laws

Multiplying state laws on marketing and distribution disclosures might be pre-empted by new federal legislation


Lee Shapiro, Allscripts, LLC USA

Latest:

Leveraging the EHR to Advance Clinical Research

Converging the processes and data from EHRs and from the electronic data-capture (EDC) of the clinical research environment could change the paradigm of drug development and safety


Wendy White, Siren Interactive

Latest:

Building bridges to rare disease patients

Orphan drug development and marketing have important distinct requirements for R&D, regulatory and marketing



Robin Kinard, PPD

Latest:

The dynamic evolution of multi-sponsor REMS

Risk Evaluation & Mitigation Strategy (REMS) programs are evolving, with new complexities for compliance managers




Gregory Crouse

Latest:

Risky Business: What Life Sciences Need to Know About the US Foreign Corrupt Practices Act Before an Acquisition

Nearly 30% of acquiring companies do not evaluate FCPA risks prior to an acquisition


Jeff Antos, The Weinberg Group

Latest:

PRIMES: The six key elements of successful drug/device development

Guidance for companies starting out on the commercialization path


Philip Kouyoumdjian, Cozen O'Connor

Latest:

Supreme Court: reverse payment settlements subject to antitrust scrutiny

What are the risks of future 'pay for delay' settlements between branded and generic manufacturers?


F.J. Quinn, Contributing Editor

Latest:

New cold chain solutions meet regulatory, shipper requirements

Cold chain packagers balance cost, performance and compliance approaches


Suzanne Shelley, Contributing Editor

Latest:

Specialty Pharmacy: The Trends Shaping Best Practices

When it comes to navigating the complex clinical and commercial landscape for specialty drugs—including hurdles in access to these critical but costly therapies—today’s specialty pharmacies are bringing more skills and services to the table.


Frank Celia, Contributing Editor

Latest:

Pharma ups the ante on DTC advertising

Despite the buzz around digital media channels, pharma continues to pour marketing dollars into television


Rob Ririe, Blue Fin Group

Latest:

Managing government pricing programs

When state and federal governments are involved, prices and reimbursements have both regulatory and financial consequences



Jennifer Fillman, Cardinal Health Specialty Solutions

Latest:

Getting products to market fast with the 3PL Title Model

A contractual arrangement that could save time and money for brand owners


Heather Morel, PhD, SVP/GM, Access & Adherence, RxCrossroads by McKesson

Latest:

Evolving Patient Access Programs for Specialty Therapies

When a physician prescribes or treats a patient with your specialty drug, the stakes are high for everyone. Patient access is evolving to improve the patient and physician journey with specialty therapies


Larri Short, Arent Fox

Latest:

Lessons learned on bona fide service fees and fair market value-is there a 'right answer'?

Recent regulatory actions and court cases highlight the importance of due diligence in reporting the value of service fees when federal reimbursements are concerned. The financial consequences can be substantial


Barry Fortner, ION Solutions, AmerisourceBergen Specialty Group

Latest:

Why community oncology matters

Oncology is the market for today's pipeline products. Here's why the community setting needs to be preserved as a primary site of care to administer those products


Arno Sosna, Veeva Systems

Latest:

Machine learning finds purpose in commercial life sciences

Machine learning offers business knowledge based on the data that marketers and sales teams generate



By Rob Stevens, Tive

Latest:

Data logging is not enough for a modern pharma supply chain

IoT takes you from living in the past to shaping the future


By Will Febbo, OptimizeRx

Latest:

Connecting with physicians—and patients—at the point of care

Integrating pharma communications with electronic health-record systems brings value to patients and providers


Morna White, Quintiles

Latest:

The Rising Importance of Observational Research

International efforts to standardize guidelines for observational research could move the entire field forward


Sally Lorimer, ZS Associates, Inc.

Latest:

Change is a constant for sales incentive planning

Sales Compensation Solutions, a new book from ZS Associates, outlines problems and solutions

© 2024 MJH Life Sciences

All rights reserved.